A growing coalition of US states has formally objected to a provision in Florida’s $10m settlement with generic drugmaker Sandoz, arguing it unfairly restricts their ability to negotiate independent and potentially larger payouts.
In a motion filed in federal court, 20 states plus the District of Columbia and US
The